Ms Izabela Todorovski
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
12 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Enhanced efficacy of a specific HDAC3 inhibitor in combination with 5-azacitidine against diffuse large B-cell lymphoma
DOI: 10.1016/j.bneo.2026.1002142025
Journal article
A CDK11-dependent RNA polymerase II pause-checkpoint precedes CDK9-mediated transition to transcriptional elongation
DOI: 10.1016/j.molcel.2025.08.0012025
Journal article
PAF1C-mediated activation of CDK12/13 kinase activity is critical for CTD phosphorylation and transcript elongation
DOI: 10.1016/j.molcel.2025.04.0122025
Journal article
Lipid-metabolism-focused CRISPR screens identify enzymes of the mevalonate pathway as essential for prostate cancer growth
DOI: 10.1016/j.celrep.2025.1154702024
Journal article
RNA kinetics influence the response to transcriptional perturbation in leukaemia cell lines
DOI: 10.1093/narcan/zcae0392023
Other
Supplementary Table from Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
DOI: 10.1158/2159-8290.22541167.v12022
Journal article
Epigenetic modulators of B cell fate identified through coupled phenotype-transcriptome analysis
DOI: 10.1038/s41418-022-01037-5
RECENT SCHOLARLY WORKS
2022
Journal article
Distinct modulation of IFNγ-induced transcription by BET bromodomain and catalytic P300/CBP inhibition in breast cancer
DOI: 10.1186/s13148-022-01316-52022
Journal article
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML
DOI: 10.1158/2159-8290.CD-20-11452021
Journal article
The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer
DOI: 10.1016/j.cell.2021.04.022